UK Markets open in 7 hrs 26 mins

Ocugen, Inc. (OCGN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.8824+0.0524 (+6.31%)
At close: 04:00PM EDT
0.8900 +0.01 (+0.86%)
After hours: 07:32PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.8300
Bid0.8785 x 3200
Ask0.8920 x 900
Day's range0.8400 - 0.8979
52-week range0.8300 - 3.7000
Avg. volume7,000,215
Market cap193.146M
Beta (5Y monthly)3.71
PE ratio (TTM)N/A
EPS (TTM)-0.2530
Earnings date04 May 2023 - 08 May 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est5.33
  • Simply Wall St.

    Ocugen, Inc. (NASDAQ:OCGN): Is Breakeven Near?

    With the business potentially at an important milestone, we thought we'd take a closer look at Ocugen, Inc.'s...

  • Motley Fool

    Why Ocugen Stock Eked Out a Win Today

    Investors were pleased, if not overwhelmingly so, with Ocugen's (NASDAQ: OCGN) latest set of quarterly results on Tuesday. The biotech published its fourth-quarter and full-year figures that morning, in addition to providing a business update. Ocugen is a clinical-stage biotech that has no revenue at the moment.

  • Motley Fool

    Ocugen (OCGN) Q4 2022 Earnings Call Transcript

    Joining me today are Ocugen's chairman, CEO, and co-founder, Dr. Shankar Musunuri, who will provide a business update; and our chief accounting officer and senior vice president of finance, Jessica Crespo, who will provide more detail on our financial results. This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties.